Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Leukemia

Free Subscription Articles published in Int J Hematol Retrieve available abstracts of 107 articles: HTML format Text format

Single Articles

January 2012
1. GAVINI A , Telang GH, Olszewski AJ
   Generalized purpuric drug exanthem with hemorrhagic plaques following bendamustine chemotherapy in a patient with B-prolymphocytic leukemia.
   Int J Hematol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. ITONAGA H , Tsushima H, Hata T, Matsuo E, et al
   Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.
   Int J Hematol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. NEY-GARCIA DR , Liehr T, Bhatt S, de Souza MT, et al
   Childhood B-cell progenitor acute lymphoblastic leukemia presenting a three-way t(11;12;21)(q14;p13;q22) with a RUNX1 gene signal on chromosome 11.
   Int J Hematol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   December 2011
4. YOKOHAMA A , Saitoh A, Nakahashi H, Mitsui T, et al
   TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients.
   Int J Hematol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. YAGI T , Ishikawa J, Aono N, Yamashita Y, et al
   Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.
   Int J Hematol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. TSUKAMOTO S , Takeuchi M, Kawajiri C, Tanaka S, et al
   Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.
   Int J Hematol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. TACHIBANA T , Tanaka M, Takasaki H, Numata A, et al
   Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation.
   Int J Hematol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
8. KAWANO N , Okuda S, Yoshida S, Kugimiya H, et al
   Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation.
   Int J Hematol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. SHIGEMATSU A , Tanaka J, Suzuki R, Atsuta Y, et al
   Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia.
   Int J Hematol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
10. LI Y , Yin S, Nie D, Xie S, et al
    MK886 inhibits the proliferation of HL-60 leukemia cells by suppressing the expression of mPGES-1 and reducing prostaglandin E2 synthesis.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. WANG Y , Gu M, Mi Y, Qiu L, et al
    Clinical characteristics and outcomes of mixed phenotype acute leukemia with Philadelphia chromosome positive and/or bcr-abl positive in adult.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. ISHIDA T , Ueda R
    Antibody therapy for Adult T-cell leukemia-lymphoma.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
13. NISHI Y , Hamamoto K, Fujita N, Okada S, et al
    Empty sella/pituitary atrophy and endocrine impairments as a consequence of radiation and chemotherapy in long-term survivors of childhood leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. TAKAGI K , Kawai Y, Yamauchi T, Iwasaki H, et al
    Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. YAMANOUCHI J , Hato T, Niiya T, Miyoshi K, et al
    A new four-way variant t(5;17;15;20)(q33;q12;q22;q11.2) in acute promyelocytic leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. KIM D , Goh HG, Kim SH, Cho BS, et al
    Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. RAZGA F , Racil Z, Machova Polakova K, Buresova L, et al
    The predictive value of human organic cation transporter 1 and ABCB1 expression levels in different cell populations of patients with de novo chronic myelogenous leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
18. KADONO M , Kakihana K, Endo I, Kawamura M, et al
    Osteonecrosis of the humeral head.
    Int J Hematol. 2011;94:222-3.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
19. ARITA K , Kondo T, Sugita J, Shigematsu A, et al
    Sequential chemotherapy and myeloablative allogeneic hematopoietic stem cell transplantation for refractory acute lymphoblastic leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. INOKUCHI K , Wakita S, Hirakawa T, Tamai H, et al
    RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. TANIMURA A , Yujiri T, Tanaka Y, Tanaka M, et al
    Activation of the unfolded protein response in primary acute myeloid leukemia cells.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
22. NAKAZATO T , Suzuki K, Mihara A, Sanada Y, et al
    Urachal remnant infection leading to Pseudomonas aeruginosa bacteremia in induction therapy for adult B-cell acute lymphoblastic leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
23. SHIMA Y , Kitabayashi I
    Deregulated transcription factors in leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. LIU H , Chiang MY, Pear WS
    Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
25. IWAMOTO S , Deguchi T, Ohta H, Kiyokawa N, et al
    Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. HEIDEL FH , Mar BG, Armstrong SA
    Self-renewal related signaling in myeloid leukemia stem cells.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. SHIRASAKI R , Tashiro H, Oka Y, Sugao T, et al
    Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19).
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. WANG H , Chen XQ, Geng QR, Liu PP, et al
    Induction therapy using the MRC UKALLXII/ECOG E2993 protocol in Chinese adults with acute lymphoblastic leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. ZHAO Y , Tan Y, Wu G, Liu L, et al
    Berbamine overcomes imatinib-induced neutropenia and permits cytogenetic responses in Chinese patients with chronic-phase chronic myeloid leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. TOMINAGA-SATO S , Tsushima H, Ando K, Itonaga H, et al
    Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
    Int J Hematol. 2011;94:81-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
31. RUSAK M , Osada J, Pawlus J, Chociej-Stypulkowska J, et al
    Utility of laboratory tests in B-CLL patients in different clinical stages.
    Int J Hematol. 2011;93:736-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. MATSUBAYASHI T , Shimizu S, Kitazawa H, Matsubayashi R, et al
    Rebound enlargement of an ectopic cervical thymus mimicking relapse of lymphoblastic lymphoma.
    Int J Hematol. 2011;93:689-90.
    PubMed     Text format     Related articles   
    
    
    
    
33. TANABE T , Yamaguchi N, Matsuda K, Yamazaki K, et al
    Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population.
    Int J Hematol. 2011;93:771-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ABBASS K , Dewani S, Markert R, Kaplon MK, et al
    Plasmacytoma presenting as hematuria.
    Int J Hematol. 2011;93:825-6.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
35. TSUBOKURA M , Yamashita T, Kageyama SI, Endo I, et al
    Ocular palsy associated with aggressive NK-cell leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
36. GE J , Hou R, Liu Q, Zhu R, et al
    Stromal-derived factor-1 deficiency in the bone marrow of acute myeloid leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. KOBAYASHI Y , Sakamaki H, Fujisawa S, Ando K, et al
    Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. GOYAMA S , Mulloy JC
    Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
39. NAKAMAE H , Shibayama H, Kurokawa M, Fukuda T, et al
    Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
40. NINOMIYA S , Kanemura N, Tsurumi H, Kasahara S, et al
    Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
41. YOSHIDA C , Komeno T, Hori M, Kimura T, et al
    Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
42. SASASE S , Yoshida H, Matsumura R, Miyashita E, et al
    Anthracyclines for acute lymphoblastic leukemia in a child with congenital long QT syndrome.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
43. TANG J , Liu Y, Chen J, Xue H, et al
    Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. KATO M , Koh K, Kikuchi A, Toyama D, et al
    Case series of pediatric acute leukemia without a peripheral blood abnormality, detected by magnetic resonance imaging.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. ICHIKAWA K , Noguchi M, Imai H, Sekiguchi Y, et al
    A case of T cell prolymphocytic leukemia involving blast transformation.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. LIU H , Long J, Zhang PH, Li K, et al
    Elevated beta-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. SHONO Y , Kosugi-Kanaya M, Shiratori S, Sugita J, et al
    Donor cell leukemia after umbilical cord blood transplantation: recurrent or de novo? The importance of diagnosis for therapeutic decision making.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
48. AOKI T , Nishiyama T, Imahashi N, Kitamura K, et al
    A highly positive nonspecific esterase reaction in a t(15;17)(q22;q12) acute promyelocytic leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
49. HUANG BT , Wang Y, Du QF, Yang J, et al
    Analysis of efficacy and cost-effectiveness of high-dose arabinoside versus daunorubicin chemotherapy in older adult patients with acute myeloid leukemia by cytogenetic risk profile: retrospective review from China.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. NADARAJAN VS , Phan CL, Ang CH, Liang KL, et al
    Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. GOTO H , Inukai T, Inoue H, Ogawa C, et al
    Erratum to: Acute lymphoblastic leukemia and Down syndrome: the collaborative study of the Tokyo Children's Cancer Study Group and the Kyushu Yamaguchi Children's Cancer Study Group.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
52. REZVANI K
    Peptide vaccine therapy for leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. ZHANG YY , Xie KM, Yang GQ, Mu HJ, et al
    The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. YAMANE A , Mori T, Kato J, Ono Y, et al
    Discrepancy in the kinetics of total and active anti-thymocyte globulin blood concentrations in recipients of allogeneic hematopoietic stem cell transplantation.
    Int J Hematol. 2011;93:406-7.
    PubMed     Text format     Related articles   
    
    
    
    
55. TACHIBANA T , Tanaka M, Takasaki H, Numata A, et al
    Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies.
    Int J Hematol. 2011;93:368-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. FURUKAWA T , Narita M, Koike T, Takai K, et al
    Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical stu
    Int J Hematol. 2011;93:336-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
57. OZONO S , Inada H, Nakagawa SI, Ueda K, et al
    Juvenile myelomonocytic leukemia characterized by cutaneous lesion containing Langerhans cell histiocytosis-like cells.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. YOSHIZATO T , Nannya Y, Yoshiki Y, Nakamura F, et al
    Nilotinib-induced hypothyroidism in a patient with chronic myeloid leukemia.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. ZHANG L , Zhu X, Zou Y, Chen Y, et al
    Effect of arsenic trioxide on the treatment of children with newly diagnosed acute promyelocytic leukemia in China.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. GOTO H , Inukai T, Inoue H, Ogawa C, et al
    Acute lymphoblastic leukemia and Down syndrome: the collaborative study of the Tokyo Children's Cancer Study Group and the Kyushu Yamaguchi Children's Cancer Study Group.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. OKADA M , Satake A, Kaida K, Taniguchi K, et al
    Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene.
    Int J Hematol. 2011;93:243-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. PIDALA J , Roman-Diaz J, Kim J, Nishihori T, et al
    Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications.
    Int J Hematol. 2011;93:206-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. CHENG CC , Ueng SH, Li HY, Chen HW, et al
    Post-tonsillectomy pulmonary complication in a patient with tonsillar myeloid sarcoma.
    Int J Hematol. 2011;93:220-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. MURAMATSU H , Takahashi Y, Sakaguchi H, Shimada A, et al
    Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era.
    Int J Hematol. 2011;93:186-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. MATSUI Y , Miura Y, Sugino N, Kaneko H, et al
    Methotrexate-associated lymphoplasmacytic lymphoma complicated with type 2 cryoglobulinemia.
    Int J Hematol. 2011;93:253-6.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
66. SAKAI K , Ishikawa Y, Mori Y, Kobayashi M, et al
    A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance: sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. VALENTINI CG , Bozzoli V, Fianchi L, Voso MT, et al
    Primary plasma cell leukemia followed by testicular plasmacytoma.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. YOSHIDA M , Akiyama N, Fujita H, Miura K, et al
    Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. OHTA H , Iwamoto S, Kiyokawa N, Tsurusawa M, et al
    Flow cytometric analysis of de novo acute myeloid leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
70. DE SOUZA MT , Mkrtchyan H, Hassan R, Ney-Garcia DR, et al
    Secondary abnormalities involving 1q or 13q and poor outcome in high stage Burkitt leukemia/lymphoma cases with 8q24 rearrangement at diagnosis.
    Int J Hematol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. LI X , Wu Y, Chen Y
    Down-regulating the expression of IL-3Rbeta interfered with the proliferation, not differentiation in NB4 cells.
    Int J Hematol. 2011;93:83-90.
    PubMed     Text format     Related articles   
    
    
    
    
72. MORI T , Nakamura Y, Kato J, Yamane A, et al
    Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
    Int J Hematol. 2011;93:132-4.
    PubMed     Text format     Related articles   
    
    
    
    
73. SELLMANN L , de Beer D, Bartels M, Opalka B, et al
    Telomeres and prognosis in patients with chronic lymphocytic leukaemia.
    Int J Hematol. 2011;93:74-82.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
74. WADA A , Kobayashi N, Asanuma S, Matsuoka S, et al
    Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. LEE GY , Shim JS, Cho B, Jung JY, et al
    Stochastic acquisition of a stem cell-like state and drug tolerance in leukemia cells stressed by radiation.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. SUZUKI R
    Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
77. SUEMORI K , Fujiwara H, Watanabe S, Azuma T, et al
    A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11 months.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
78. KWONG YL
    Hematopoietic stem cell transplantation in natural killer cell lymphoma and leukemia.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. GOGTAY J , Chahchad S, Jadhav S, Purandare S, et al
    Response to the case report by Mattar: Generic Imatinib (Imatib, Cipla) in a patient with chronic myeloid leukemia in chronic phase.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
80. ISHITSUKA K , Katsuya H, Toyota T, Ishizu M, et al
    Interferon-alpha and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma: case reports of Japanese patients.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
81. ZHANG K , Li J, Meng W, Xing H, et al
    C/EBPbeta and CHOP participate in Tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. ICHIKAWA M , Hangaishi A, Nannya Y, Kurokawa M, et al
    Postremission gemtuzumab ozogamicin for elderly patients with acute myelogenous leukemia with favorable characteristics and comorbid conditions.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
83. MINAMI Y , Kajiguchi T, Abe A, Ohno T, et al
    Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. KIM HJ , Kim MJ, Lee MJ, Ahn JH, et al
    Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. TSUJIMURA A , Kiyoi H, Shiotsu Y, Ishikawa Y, et al
    Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. CHANG H , Shuai X, Ma HB, Liu T, et al
    A case report of acute lymphoblastic leukemia complicated by lactic acidosis.
    Int J Hematol. 2010;92:538-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. TAKAHASHI N , Kameoka Y, Tagawa H, Saitoh H, et al
    Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate.
    Int J Hematol. 2010;92:559-61.
    PubMed     Text format     Related articles   
    
    
    
    September 2010
88. YOSHIDA K , Hasegawa D, Takusagawa A, Kato I, et al
    Bullous exudative retinal detachment due to infiltration of leukemic cells in a child with acute lymphoblastic leukemia.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. KIKUCHI M , Tanaka J, Kondo T, Hashino S, et al
    Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. JINNAI I , Sakura T, Tsuzuki M, Maeda Y, et al
    Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. IMAGAWA J , Harada Y, Yoshida T, Sakai A, et al
    Giant granulocytic sarcoma of the vagina concurrent with acute myeloid leukemia with t(8;21)(q22;q22) translocation.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
92. ONO Y , Mori T, Kato J, Yamane A, et al
    Hemorrhagic colonic ulcers caused by dasatinib for chronic myelogenous leukemia.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
93. ISHIDA Y , Terasako K, Oshima K, Sakamoto K, et al
    Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. FUJINO H , Fujita N, Hamamoto K, Oobu S, et al
    Ring/marker chromosome derived from chromosome 7 in childhood acute megakaryoblastic leukemia with monosomy 7.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. KOTANI A , Harnprasopwat R, Toyoshima T, Kawamata T, et al
    miRNAs in normal and malignant B cells.
    Int J Hematol. 2010;92:255-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
96. CHIAMPANICHAYAKUL S , Anuchapreeda S, Chruewkamlow N, Mahasongkram K, et al
    Production of monoclonal antibodies to P-glycoprotein: its application in detection of soluble and surface P-glycoprotein of leukemia patients.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. MALE HJ , Davis MB, McGuirk JP, Abhyankar S, et al
    Blastic plasmacytoid dendritic cell neoplasm should be treated with acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remission.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. KAMEDA T , Shide K, Shimoda HK, Hidaka T, et al
    Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. LEE SE , Kim HJ, Min WS, Cho BS, et al
    Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities.
    Int J Hematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. JEKARL DW , Kim M, Lim J, Kim Y, et al
     CD56 antigen expression and hemophagocytosis of leukemic cells in acute myeloid leukemia with t(16;21)(p11;q22).
     Int J Hematol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. YOSHIDA H , Matsumura R, Sato E, Hashii Y, et al
     Late-onset differentiation syndrome in a child with acute promyelocytic leukemia.
     Int J Hematol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
102. YOKOYAMA H , Mori SI, Kobayashi Y, Kurosawa S, et al
     Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patients.
     Int J Hematol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
103. RICE KN , Jamieson CH
     Molecular pathways to CML stem cells.
     Int J Hematol. 2010;91:748-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. GOYAMA S , Kurokawa M
     Evi-1 as a critical regulator of leukemic cells.
     Int J Hematol. 2010;91:753-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. OKTENLI C , Sayan O, Celik S, Erikci AA, et al
     High frequency of MEFV gene mutations in patients with myeloid neoplasm.
     Int J Hematol. 2010;91:758-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. NAGATA Y , Ohashi K, Fukuda S, Kamata N, et al
     Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion.
     Int J Hematol. 2010;91:799-807.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
107. CHEN Y , Gu L, Zhou C, Wu X, et al
     Relapsed APL patient with variant NPM-RARalpha fusion responded to arsenic trioxide-based therapy and achieved long-term survival.
     Int J Hematol. 2010;91:708-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: